Loading…
Fierce Drug Dev Forum 2019 has ended
avatar for David Thompson, Ph.D.

David Thompson, Ph.D.

SYNEOS HEALTH
Senior Vice President, Real World Research
Dave is a health economist by training with 25+ years of experience conducting real-world research and consulting for clients in the biopharmaceutical sector. His work has been global in nature, with extensive experience in North American & European markets as well as the emerging markets of the Asia-Pacific and Latin American regions. 
Dave is a frequent contributor to the International Society for Pharmacoeconomics & Outcomes Research (ISPOR), having functioned as Editor-in-Chief of ISPOR’s publication, Value & Outcomes Spotlight, from 2008 to the present.
Dave is a steering committee member of the Clinical Trials Transformation Initiative (CTTI), a multistakeholder initiative of Duke University and the US Food & Drug Administration, and a member of the CTTI initiative in real-world evidence (RWE). He also serves on the advisory board of the Duke-Margolis real-world evidence consortium.
Dave holds degrees from the University of California Riverside (BS, Economics) and University of Massachusetts (MA, Economics; PhD, Economics).

My Speakers Sessions

Tuesday, October 29
 

9:45am